Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Toronto S.E.
2026-08-27
|
5-day change | 1st Jan Change | ||
| 0.1100 CAD | 0.00% |
|
0.00% | -15.38% |
| Market Cap | 41.54M 29.97M 25.72M 24.08M 22.05M 2.86B 41.66M 285M 111M 1.44B 113M 110M 4.77B | P/E 2026 * |
-3.67x | P/E 2027 * | -2.75x |
|---|---|---|---|---|---|
| Enterprise Value | 41.54M 29.97M 25.72M 24.08M 22.05M 2.86B 41.66M 285M 111M 1.44B 113M 110M 4.77B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 8.31x |
| Free-Float |
86.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 month | -8.33% | ||
| 3 months | -21.43% | ||
| 6 months | -21.43% | ||
| Current year | -15.38% |
| 1 week | 0.1 |  | 0.12 |
| 1 month | 0.1 | | 0.12 |
| Current year | 0.1 | | 0.2 |
| 1 year | 0.1 | | 0.2 |
| 3 years | 0.1 | | 0.91 |
| 5 years | 0.1 | | 2.22 |
| 10 years | 0.1 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 2024-08-11 |
James Parsons
DFI | Director of Finance/CFO | 60 | 2024-10-10 |
David Burke
IRC | Investor Relations Contact | - | 2024-10-10 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 2012-04-18 |
Steven Sangha
BRD | Director/Board Member | - | 2023-04-23 |
David Paterson
BRD | Director/Board Member | - | 2024-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/3/26 | Sell | Company | -115,000 | 0.0305% | ||
| 5/22/26 | Option | Chairman | 228,912 | 0.0658% | ||
| 5/22/26 | Option | Director | 260,000 | 0.0748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -40.54% | -85.33% | 29.97M | |
| -2.29% | -1.70% | -18.07% | +15.82% | 124B | |
| -1.31% | -0.87% | -23.24% | -1.28% | 12.26B | |
| +0.74% | -1.61% | +91.24% | +146.22% | 10.72B | |
| +2.13% | -4.21% | -51.63% | -68.92% | 4.21B | |
| +0.57% | +4.02% | -22.01% | +58.76% | 2.73B | |
| -1.59% | -0.73% | -34.11% | -71.78% | 1.76B | |
| +1.12% | -0.84% | -23.32% | -12.99% | 1.63B | |
| +0.47% | -3.59% | -36.96% | -38.68% | 1.6B | |
| Average | -0.01% | -0.16% | -17.63% | -6.46% | 17.61B | |
| Weighted average by Cap. | -1.77% | -1.40% | -12.46% | +19.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 5M 3.61M 3.1M 2.9M 2.65M 344M 5.01M 34.32M 13.42M 174M 13.54M 13.25M 575M |
| Net income | -12.83M -9.25M -7.94M -7.44M -6.81M -884M -12.86M -88.05M -34.42M -445M -34.74M -33.99M -1.47B | -19.77M -14.26M -12.24M -11.46M -10.5M -1.36B -19.83M -136M -53.06M -687M -53.55M -52.39M -2.27B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | CA$0.1100 | 0.00% | 51,456 |
| 26-08-26 | CA$0.1100 | 0.00% | 4,000 |
| 26-08-25 | CA$0.1100 | 0.00% | 68,110 |
| 26-08-24 | CA$0.1100 | 0.00% | 40,202 |
| 26-08-21 | CA$0.1100 | 0.00% | 121,565 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.1100CAD
Average target price
0.4500CAD
Spread / Average Target
+309.09%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
